Allogenic Adipose-derived Mesenchymal Stem Cells (AMSCs) for Epilepsy During Deep Brain Stimulation (DBS) Surgery
EARLY_PHASE1
5
about 1.3 years
18–75
1 site in FL
What this study is about
Researchers are testing the safety and feasibility of delivering adipose-derived mesenchymal stem cells directly into the thalamus during deep brain stimulation surgery for epilepsy. The trial will last up to a year after treatment application, with follow-up visits including surgical, clinical, and radiographic data.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take AMSCs
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Incidence of AEs related to the study agent, Radiographic effects related to the study agent
Neurology